News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dow Global Technologies Inc. Announces License Agreement with Serum Institute of India, Ltd.



2/27/2007 1:55:53 PM

Midland, Mich. - February 27, 2007 -- Dow Global Technologies Inc. today announced that Serum Institute of India Limited has entered into a commercial license agreement for Pfenex Expression Technologyâ„¢, a Pseudomonas-based technology from DowpharmaSM. The first product under the agreement is a confidential proprietary protein for which a high-yield production strain has already been developed by Dowpharma. Dowpharma will transfer the production strain to Serum Institute of India with full support for its regulatory filing.


Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES